Skip to main content
. 2022 Sep 9;11(18):5308. doi: 10.3390/jcm11185308
ADT advanced targeted therapies
IMID immune-mediated inflammatory diseases
IBD inflammatory bowel diseases
RA rheumatoid arthritis
PA psoriatic arthritis
SM small molecules